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Abstract
Background Amputation has been the standard surgical
treatment for distal tibia osteosarcoma owing to its unique
anatomic features. Preliminary research suggested that
microwave-induced hyperthermia may have a role in
treating osteosarcoma in some locations of the body (such
as the pelvis), but to our knowledge, no comparative study
has evaluated its efficacy in a difficult-to-treat location like
the distal tibia.
Questions Does microwave-induced hyperthermia result
in (1) improved survival, (2) decreased local recurrence,
(3) improved Musculoskeletal Tumor Society (MSTS)
scores, or (4) fewer complications than amputation in
patients with a distal tibial osteosarcoma?
Methods Between 2000 and 2015, we treated 79 patients
for a distal tibia osteosarcoma without metastases. Of
those, 52 were treated with microwave-induced hyper-
thermia, and 27 with amputation. Patients were considered
eligible for microwave-induced hyperthermia if they had
an at least 20-mm available distance from the tumor edge
to the articular surface, good clinical and imaging response
to neoadjuvant chemotherapy, and no pathologic fracture.
Patients not meeting these indications were treated with
amputation. In addition, if neither the posterior tibial artery
nor the dorsalis pedis artery was salvageable, the patients
were treated with amputation and were not included in any
group in this study. A total of 13 other patients were treated
with conventional limb-salvage resections and reconstruc-
tions (at the request of the patient, based on patient
preference) and were not included in this study. All 79
patients in this retrospective study were available for fol-
lowup at a minimum of 12 months (mean followup in the
hyperthermia group, 79 months, range 12–158 months;
mean followup in the amputation group, 95 months, range,
15–142 months). With the numbers available, the groups
were no different in terms of sex, age, tumor grade, tumor
stage, or tumor size. All statistical tests were two-sided,
and a probability less than 0.05 was considered statistically
significant. Survival to death was evaluated using Kaplan-
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Meier analysis. Complications were recorded from the
patients’ files and graded using the classification of surgical
complications described by Dindo et al.
Results In the limb-salvage group, Kaplan Meier survival
at 6 years was 80% (95% CI, 63%–90%), and this was not
different with the numbers available from survivorship in
the amputation group at 6 years (70%; 95% CI, 37%–90%;
p = 0.301).With the numbers available, we found no dif-
ference in local recurrence (six versus 0; p = 0.066).
However mean ± SD MSTS functional scores were higher
in patients who had microwave-induced hyperthermia
compared with those who had amputations (85% ± 6%
versus 66% ± 5%; p = 0.008).With the numbers available,
we found no difference in the proportion of patients
experiencing complications between the two groups (six of
52 [12%] versus three of 27 [11%]; p = 0.954).
Conclusions We were encouraged to find no early dif-
ferences in survival, local recurrence, or serious
complications between microwave-induced hyperthermia
and amputation, and a functional advantage in favor of
microwave-induced hyperthermia. However, these findings
should be replicated in larger studies with longer mean
duration of followup, and in studies that compare micro-
wave-induced hyperthermia with conventional limb-
sparing approaches.
Level of Evidence Level III, therapeutic study.
Introduction
The tibia is the second most-common site of osteosarcoma,
accounting for 19% of all osteosarcomas, with 20% of
those occurring in the distal tibia [22]. Amputation has
long been regarded as the standard surgical treatment for
these tumors, with satisfactory functional results when an
appropriate prosthesis is used [25]. With the advances in
chemotherapy and surgical techniques, limb salvage has
become the preferred treatment when possible. However,
other than in locations like those surrounding the hip or
knee, it is difficult to perform a safe, negative-margin
resection in the distal tibia because of its subcutaneous
location and the proximity of the distal tibia to the neu-
rovascular bundle and tendons [18]. Complications, poor
function, and decreased durability of the reconstruction are
difficult to avoid in this location [19].
Conflicting findings regarding survival and function
after limb salvage and amputation for patients with
osteosarcoma of the distal tibia have been reported
[2, 4, 15, 19, 20, 26]. While survivorship of patients who
undergo amputation for distal tibia osteosarcoma generally
is high [26] and complications are disconcertingly frequent
[4], function as measured by the Musculoskeletal Tumor
Society (MSTS) [6] score after amputation is generally low
[15]. Small series of patients undergoing limb salvage for
osteosarcoma in this location are not always dramatically
better in terms of function [20], complications are likewise
common [25], and survivorship seems even worse [18]. For
this reason, we believe the best surgical option for patients
who have osteosarcoma of the distal tibia is unclear.
Hyperthermia has been introduced as an alternative
treatment method for osteosarcoma [8]. It is capable of
accurately killing tumor cells while tending to minimize
injury to the surrounding tissue, perhaps facilitating
resections in difficult-to-access locations. Hyperthermia
can be used to achieve acceptable local disease control
while maintaining the structural integrity of the skeleton in
some patients [9]. This technique may reduce the need for
complex reconstruction, and so seems appealing in terms
of potential functional benefits; however, this is unproven
for patients with osteosarcoma of the distal tibia. In this
setting, microwave-induced hyperthermia is administered
to the tumor bed and causes immediate heat necrosis of
the tumor and adjacent tissues, followed by limited sur-
gical excision of the mass with preservation of the
surrounding skeleton. Because of its perceived benefits,
we have used microwave-induced hyperthermia in patients
with malignant bone tumors for 20 years in our depart-
ment [7, 8]; however, no formal study has compared
microwave-induced hyperthermia with the conventional
treatment (transtibial amputation), and it seems important
to do so.
We therefore asked: Does microwave-induced hyper-
thermia result in (1) improved survival, (2) decreased local
recurrence, (3) improved MSTS scores, or (4) fewer
complications than amputation in patients with a distal
tibial osteosarcoma?
Patients and Methods
The research was approved by the Ethics Review Com-
mittee of Tangdu Hospital, Xian, Shanxi, China (approval
ID 2016016), and written informed consent was obtained
from all participating patients.
Cohort Selection
Between 2000 and 2015, we treated 106 patients for distal
tibia osteosarcoma without metastases. Of those, 52 were
treated with microwave-induced hyperthermia (Table 1),
and 41 with amputation. A total of 13 patients who would
have met our indications for microwave-induced hyper-
thermia were instead treated with the conventional limb-
salvage resection and reconstruction based on the patient’s
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1/F/31 IIA 3 11.6 +
2/M/9 IIA 4 8.8 +
3/M/28 IIB 4 9.5 +
4/F/20 IB 3 12.3 +
5/F/33 IIA 4 4.6 +
6/M/25 IIB 2 13.6 +
7/F/53 IB 4 12.8 +
8/M/26 IIA 4 11.6 +
9/M/50 IB 1 9.1 +
10/F/12 IIB 4 20.6
11/M/21 IIA 2 12.5 +
12/F/23 IB 4 15.2 +
13/M/32 IIA 2 11.4 +
14/F/25 IIB 4 12.5 +
15/F/23 IB 1 7.8 +
16/M/34 IIA 4 6.6 +
17/M/23 IIB 3 13.2 +
18/F/44 IB 4 14.6 +
19/M/39 IIB 1 15.1 +
20/F/40 IIB 4 12.3 +
21/M/38 IA 4 8.9 +
22/M/18 IIA 2 9.7 +
23/F/14 IIA 4 6.8 +
24/M/20 IIB 3 15.2 +
25/M/30 IIA 2 9.4 +
26/M/52 IA 4 8.3 +
27/F/8 IIA 4 8.1 +
28/M/32 IIA 2 7.6 +
29/F/23 IA 4 15.5 +
30/M/27 IIA 3 13.1 +
31/F/20 IIB 1 16.8 +
32/M/34 IIA 4 8.7 +
33/F/25 IIA 3 13.3 +
34/M/20 IA 2 4.2 +
35/M/44 IIB 4 8.8 +
36/F/27 IIA 4 12.7 +
37/M/17 IIA 1 21.2 +
38/F/18 IIA 4 12.6 +
39/M/25 IA 3 5.3 +
40/F/33 IIA 4 15.6 +
41/M/30 IIA 4 13.9 +
42/F/24 IIA 3 15.4 +
43/M/30 IA 4 13.2 +
44/M/45 IIA 4 12.5 +
45/F/28 IIA 3 15.2 +
46/M/28 IIA 4 14.7 +
47/F/12 IA 4 17.6 +
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preferences (which might have been driven by cost, per-
ceived functional demand, or other factors); these patients
were not included in this retrospective study. If neither the
posterior tibial artery nor the dorsalis pedis artery was
salvageable, patients were treated with amputation; these
patients (n = 14) were not included in any group in this
study. This left 27 patients with amputations available for
our study (Table 2) and 79 patients available for the entire
study. Patients were considered eligible for microwave-
induced hyperthermia if they had an at least 20 mm
available distance from the tumor edge to the articular
surface, good clinical (such as pain reduction) and imaging
Table 2. Details of the patients with distal tibia osteosarcoma who had amputation
Patient number/ gender/age (years) AJCC stage Histology/Broders’ grade Tumor size (cm2) Chemotherapy
1/M/21 IIB 4 10.4 +
2/M/42 IB 2 8.4 
3/M/34 IIB 4 12.9 +
4/F/26 IIB 3 11.1 +
5/M/28 IIA 3 9.2 
6/F/32 IIB 3 8.5 
7/F/15 IIA 4 11.5 +
8/F/24 IIB 4 10.6 +
9/M/16 IIB 4 9.7 
10/F/35 IIB 3 18.2
11/F/34 IIA 4 21.3 +
12/M/25 IIB 4 13.2 +
13/M/30 IIA 4 19.4 +
14/F/33 IIA 4 10.9 +
15/M/27 IIB 4 19.3 +
16/F/52 IIA 4 12.7 +
17/M/33 IB 3 11.2 +
18/F/30 IIB 4 14.6 +
19/F/29 IB 1 5.4 +
20/M/13 IIB 4 17.2 +
21/M/34 IIA 4 9.9 +
22/F/21 IIB 4 9.6 
23/F/40 IB 3 12.5 +
24/F/25 IIB 3 17.6 +
25/F/27 IIA 4 9.1 +
26/M/27 IB 3 8.6 
27/F/30 IIB 4 8.4 











48/M/21 IIA 3 18.6 +
49/M/34 IIA 4 12.9 +
50/M/27 IIA 3 15.4 +
51/F/27 IIA 3 17.8 +
52/M/40 IA 3 16.2 +
AJCC = American Joint Committee on Cancer.
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responses to neoadjuvant chemotherapy, and no pathologic
fracture. Chemonecrosis was assessed using the grading
system of Huvos et al. [14]. More than 90% necrosis on the
histologic sections was considered a good response to
chemotherapy. All patients in this series were available for
followup at a minimum of 12 months (mean followup in
the hyperthermia group, 79 months, range, 12–158 months;
mean followup in the amputation group, 95 months, range,
15–142 months).
All patients had radiographs, CT, MRI, and bone scans.
With the numbers available, we found no difference in sex
between the amputation group and microwave-induced
hyperthermia group (12 males and 15 females versus 30
males and 22 females; p = 0.263) (Table 3). We also found
no difference in age (27.5 ± 8.7 years versus 31.2 ± 6.4
years; p = 0.586), tumor grade, tumor stage, and tumor size
between the amputation group and the microwave-induced
hyperthermia group (Table 3). Of the 79 patients, 54 had a
needle biopsy and 32 had an incisional biopsy, including
those whose needle biopsy was nondiagnostic. We graded
the histologic sections based on the biopsy using Broders’
classification [1], which has four grades according to the rate
of differentiation of the tumor cells.We staged patients using
the surgical staging systems of the MSTS [6] and the
American Joint Committee on Cancer (AJCC) [24]. Nine-
teen patients had Stage I tumors and 60 had Stage II tumors.
Surgical Technique
All patients were evaluated by CT and MRI at the end of
each chemotherapy regimen preoperatively to define the
edge of the tumor, which was determined at the transition
of marrow signal from abnormal to normal. Areas of
intermediate signal intensity adjacent to the tumor edge
were regarded as part of the tumor and should be included
in the ablation area. All 79 patients received two cycles of
preoperative neoadjuvant chemotherapy based on a stan-
dard protocol which was described in a previous study [17].
Patients treated with microwave-induced hyperthermia
were evaluated according to the following criteria: (1)
assessment of tumor response or progression as assessed by
MRI; (2) distance between the ankle cartilage and the
tumor as assessed by MRI of 20 mm or more, to obtain a
bone width margin of 10 mm and a remaining residual
epiphysis of 10 mm, and wide proximal margins on the
bone resections [19] (defined as a cuff of 2 cm to 3 cm of
normal tissue remaining on all sides of the tumor); and (3)
a sufficient amount of epiphysis preserved to allow fixation
of the osteotomy junction [21]. Intraoperatively, the ade-
quacy of bone resection was evaluated with frozen section
biopsy of a tissue sample obtained from the medullary
canal of the residual tibia. For all patients who had
amputations, the margins were wide (a cuff of 2 cm to 3 cm
of normal tissue remaining on all sides of the tumor). After
surgery, the histologic margins were negative in all
patients.
All operations were performed by the same two sur-
geons (QYF and YZ). The microwave-induced
hyperthermia machine we used was the FORSEA (Xinhua
Company, Nanjing, China) [9, 10], and the microwave
generator frequency is 2450 MHz. When microwave-in-
duced hyperthermia was performed (Fig. 1), the main
principle was to dissect the tumor with a safe margin as
Table 3. Comparison of the clinical information, clinical efficacy, and incidence of complications between two groups
Variable Limb salvage (n = 52) Amputation (n = 27) p Value Statistical test
Sex (male:female) 30:22 12:15 0.263 Chi-square
Age (years) 27.5 ± 8.7 31.2 ± 6.4 0.586 Student’s t-test
Tumor grade 0.083 Chi-square
Grades 1 and 2 12 2
Grades 3 and 4 40 25
Tumor stage 0.407 Chi-square
Stage IA or IB 14 5
Stage IIA or IIB 38 22
Tumor size
B 8 cm2 7 1 0.095 Mann-Whitney U test
[ 8 cm2 45 26
Followup Mean, 75.3 months Mean, 51.2 months
Local recurrence 6 0 0.066 Chi-square
MSTS functional score 85.3 ± 5.5 65.9 ± 4.9 0.008* Student’s t-test
Complications 6 3 0.954 Chi-square
*Statistically significant.
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described above, and subsequently perform an en bloc
ablation using antenna-guided hyperthermia therapy. The
first step was to identify the extent of the tumor and dissect
the tumor-bearing bone from surrounding normal tissues
with a safe margin (at least 20 mm width). We usually use
the original dissection method of double incisions to obtain
adequate exposure (Fig. 1F). This step is very important
because it is helps to ensure the entire tumor can be killed
by microwave-induced hyperthermia. A heat-isolation pad
and wet gauze then were placed between the bone tumor
and surrounding normal tissues. Then, one to six antennas
were placed in different location of the tumor from dif-
ferent angles, matching the suction one-to-one, according
to the shape and size of the tumor to ensure the therapeutic
range and the tumor edge could be ablated adequately.
Heat output was instant when the antennas were placed,
and electromagnetic energy then was delivered to the
tumor (Fig. 1G). The tumor was ablated with direct heating
while normal soft tissues were protected from overheating.
The goal of microwave ablation is to create an ablation
zone that extends 1 cm beyond the tumor boundary at all
points with the core temperature of the tumor reaching 85
to 100C and the normal tissue temperature remaining less
than 40C for 15 to 20 minutes. During surgery, a circu-
lating cool saline system was used to protect the
surrounding normal tissues, and multiple thermocouples
were placed in various critical locations to monitor the
temperature. To avoid damaging the joint, outlet piping
which was connected with a circulating water pump and
the thermocouples were specifically placed in the ankle
cavity to keep the articular cartilage and its subchondral
bone from overheating. All the tissue blocks were evalu-
ated histologically for tumor hyperthermia necrosis and the
histologic examination showed that part of the proximal
margins were histologically negative and part of the mar-
gins were necrotic. After the dead tumor mass was
removed or curetted (Fig. 1H), the reconstruction was
performed using a mixture of bone chips and bone cement
(Fig. 1I–K) [18]. The normal shape of the tibia was
restored and prophylactic fixation was performed if nec-
essary (Fig. 1I–K).
Transtibial amputation was performed as common
practice [13].The goals and requirements were resecting
the bone 2 cm to 3 cm proximal to abnormal bone density,
obtaining adequate length of the residual limb, and
achieving good soft tissue coverage.
Postsurgery Rehabilitation and Followup
All patients in both groups were given antibiotics for 72
hours after surgery, and they performed bed exercises until
Fig. 1A–L (A) AP and (B) lateral radiographs show an osteosarcoma
of the distal tibia. (C) Pathologic examination of the tumor, and (D)
bone scans are shown. (E) The photograph shows the microwave-
induced hyperthermia machine. (F) Dissection is shown of the tumor-
bearing bone from the surrounding normal tissues with a safe margin.
(G) A wet gauze is placed between the tumor bone and surrounding
normal tissues and electromagnetic energy is delivered to the tumor
bone. (H) The dead or softened tumor is removed or curetted, (I)
followed by prophylactic fixation. (J) The defect then is filled with
allograft bone, (K) as shown in this image of the mixture of bone
cement and allograft bone chips. (L) Postoperative AP and lateral
radiographs are shown.
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wound healing was achieved. A short cast or a brace was
used for patients who had microwave-induced hyperther-
mia until there was radiographic evidence of bone union.
Signs of bony union were evaluated by serial sets of plain
radiographs [11]. All patients in both groups received
postoperative chemotherapy (adriamycin, cisplatin,
methotrexate, ifosfamide) [10]).
After discharge from the hospital, clinical and radio-
graphic followups are done every month during the first 6
months, then every 3 months during the next 2 years, and
then every 6 months. Chest CT scans were performed to
observe pulmonarymetastasis every 3months during the first
year and then every 6 months afterward. A bone scan was
performed every 6 months during the first year and then
every year. All patients have radiographs taken once a year.
The MSTS score was used to observe the function of the
patients. The status and function of the ankle were specifi-
cally assessed clinically and radiologically at followups.
Clinical Outcomes
Clinical outcomes were assessed by review of clinic notes,
supplemented by phone questionnaires, and email where
needed. Local recurrence, metastasis, complications, and
death were recorded from the patients’ files. Complications
were graded using the classification described by Dindo
et al. [3], which graded the complications at five levels.
Followup review and data were sorted and analyzed by
three of the authors (KH, NB, TY).
Statistical Analysis
All values are expressed as mean ± SD, and all error bars
represent the SD of the mean. Student’s t test and one-way
ANOVA were used to determine significance. Survival
rates were estimated using the Kaplan-Meier method. We
compared survival between the two groups using a log-rank
test. Chi-square test was used to compare complications
between the two groups. The mean, SD, and 95% CI were
provided. All statistical tests were two-sided. A probability
less than 0.05 was considered statistically significant. Sta-
tistical analyses were performed using SPSS Version 17.0
(SPSS Inc, Chicago, IL, USA).
Results
Survival
With the numbers available, there was no difference in
Kaplan-Meier survivorship between the groups. In the limb
salvage group, Kaplan Meier survival at 6 years was 80%
(95% CI, 63%–90%), and in the amputation group it was
70% at 6 years (95% CI, 37%–90%; p = 0.301) (Fig. 2). At
last followup, six of 27 patients (22%) had died in the
amputation group and nine of 52 (17%) had died in the
microwave-induced hyperthermia group.
Local Recurrence
With the numbers available, we found no difference in
local recurrence (six versus 0; p = 0.066) between the
amputation and microwave-induced hyperthermia groups.
Six of the 52 patients who had microwave-induced
hyperthermia (11.5%) (Table 1) had a local recurrence,
whereas no patients in the amputation group had a local
recurrence. The time to local recurrence was 4 to 18
months after surgery (median, 8.74 months). Two of the six
patients were treated with microwave-induced hyperther-
mia again and four underwent amputations. No patient has
had a second local recurrence.
MSTS Functional Score
However, mean ± SD MSTS functional scores were higher
in patients who had microwave-induced hyperthermia
compared with those who had amputations (85% ± 6%
versus 66% ± 5%; 95% CI of the difference, 16.01–23.10;
p = 0.008) (Table 3). At latest followup, we observed no
evidence of ankle instability, deformity, or degenerative
changes of the ankle in any of the patients who had
microwave-induced hyperthermia.
Fig. 2 A graph shows similar (log rank tests, p = 0.3014) survival for
patients with distal tibia osteosarcomas treated with microwave-
induced hyperthermia and with amputation.
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Complications
With the numbers available, we found no difference in the
proportion of patients experiencing postsurgical compli-
cations between the two groups (six of 52 [12%] versus
three of 27 [11%]; odds ratio, 1.043; 95% CI, 0.240–4.544;
p = 0.954). Complication severity, as graded according to
Dindo et al. [3], likewise was not different with the num-
bers available (p = 0.9983). Six of the 52 patients who had
microwave-induced hyperthermia (Table 3) experienced
complications. Two patients experienced delayed union
and eventually achieved union (Grade IIIb). One patient
experienced fracture and was treated with arthrodesis
(Grade IIIb). Two patients had superficial infections (Grade
I), which resolved with local dressing changes. One patient
had a deep infection (Grade IIIb), which was resolved by
irrigation, de´bridement, and administration of systemic
antibiotics.
Three of the 27 patients who had amputations (Table 1)
experienced complications. Two patients experienced
wound dehiscence and were treated with wound de´bride-
ment (Grade IIIb). One patient had a superficial infection
that resolved with local dressing changes (Grade I).
Discussion
Below-knee amputation has been regarded as the standard
surgical treatment for distal tibia osteosarcoma because of
the difficulties in reconstruction when massive bone is lost
so close to the ankle [16]. Historically, it has been very
difficult to achieve satisfactory oncologic results and
function with limb salvage in this anatomic location
because of its particular challenges [12, 16, 18]. It has been
reported that transtibial amputation provides a low risk of
local recurrence and satisfactory function [2]. However,
many patients refuse amputation for psychological or
social reasons. Microwave-induced hyperthermia has been
used with some success for two decades [7, 8]. We believe
that the biggest advantage of microwave-induced hyper-
thermia is that it may relieve the patients of the need to
have an amputation. However, to our knowledge, no
comparative study has evaluated its efficacy for patients
with distal tibia osteosarcoma. We therefore asked whether
it would provide (1) improved survival, (2) decreased local
recurrence, (3) improved MSTS scores, or (4) fewer
complications than amputation in patients with a distal
tibial osteosarcoma.
There were some limitations in this study. First, the
sample size was relatively small despite this being one of
the largest studies reported. This limited our ability to
analyze for other factors that might have influenced the
oncologic outcomes. Second, this study was a retrospective
analysis and the two groups were not randomly selected.
That being so, selection bias might have been an issue here.
Patients perceived to have a worse prognosis may have
been selected to have amputation. However, we tried to
apply consistent indications for microwave-induced
hyperthermia. In addition, the patients in whom limb sal-
vage was not considered possible (such as those in whom
neither the posterior tibial artery nor the dorsalis pedis
artery was salvageable) were not included in any group. In
general, patients were considered eligible for microwave-
induced hyperthermia if they had an at least 20 mm
available distance from the tumor edge to the articular
surface, good clinical and imaging response to neoadjuvant
chemotherapy, and no pathologic fracture. Patients not
meeting these indications were treated with amputation.
However, some patients meeting the indications for
microwave-induced hyperthermia were treated instead with
amputation or conventional limb-salvage approaches
because of the patient’s subjective wishes (such as cost,
function demand, social recognition). Two patients were
unable to afford microwave-induced hyperthermia because
of its high price and two other patients had anxiety owing
to the possibility of tumor recurrence. Finally, the followup
is relatively short. These patients need to be followed for
longer periods to ensure that the tumors do not recur and
that other complications related to treatment do not become
evident. We intend to continue to follow these patients.
With the numbers available, we found no difference in
oncologic survival between patients treated with micro-
wave-induced hyperthermia and those who had transtibial
amputation for distal tibia osteosarcoma. Other series
[12, 16, 18] have had similar results between limb salvage
and amputation for osteosarcoma of the distal tibia. How-
ever, the sample sizes in those studies are relatively smaller
and comparisons were performed mostly between different
types of reconstructions after limb salvage. Amputation is
the secondary treatment when there is recurrence or a
complication, in most cases.
Likewise,with the numbers available, the treatmentswere
no different in terms of local recurrence, although there were
some local recurrences in the microwave-induced hyper-
thermia group, and we believe that longer followup will be
important in these patients. The incidence is relatively higher
in other studies of limb salvage [5, 12, 16, 26], because it is
difficult to obtain a safe margin resection when good func-
tion is desired at the same time because of the proximity of
nerves, vessels, and tendons. When microwave-induced
hyperthermia was given, the first step was to dissect the
tumor-bearing bone from surrounding normal tissues with a
safemargin. The distance between the ankle cartilage and the
tumor as assessed by MRI was 20 mm or more to obtain a
bone width margin of 10 mm and a remaining residual epi-
physis of 10 mm. The margins of proximal bone resections
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were wide (a cuff of 2 cm to 3 cm of normal tissue remaining
on all sides of the tumor). In addition, surrounding tissues
were fully protected and multiple antennas were inserted in
different locations from different angles to ensure the ther-
apeutic range. This could account for some of the observed
recurrence benefit of microwave-induced hyperthermia in
our series. To the best of our knowledge, there were no local
recurrences reported when amputation was performed,
which is the same as in our study [5, 15, 18, 28, 29].
Our technique for microwave-induced hyperthermia
resulted in improved function compared with transtibial
amputation. Function is very important in all operations.
However, the unfortunate reality is that better function seems
to carry some risk of recurrence [2, 11, 14]. The reason for
this is that for better function less tissue needs to be removed
which could result in a high risk of recurrence.We also found
that the mean MSTS functional scores for the patients who
had microwave-induced hyperthermia were better than
scores reported in other limb salvage studies [13, 23, 24].
There could be several reasons for this, although all are
somewhat speculative. Osteotomywas not used, so the ankle
remained intact; this could account for some of the observed
functional benefit in this series. Second, we used amixture of
bone chips, cement, and prophylactic internal fixation for
reconstruction. This may have facilitated revascularization,
which has been confirmed by animal and clinical experi-
ments [9, 15, 30], and perhaps helped to reduce the likelihood
of nonunion, aseptic loosening, and allograft fracture. The
maintained intraarticular structures can provide a good oss-
eous bed for reattachment of resected soft tissues, such as
muscles and ligaments.
Finally, we did not see an important difference between
the treatment groups in terms of major complications. In
fact, complications have a relatively high incidence in the
distal tibia compared with other locations because of its
unique anatomy [15, 19]. Reported complication rates
range from 17% to 92% for patients having limb salvage
treatment [16, 18, 27]. Topping that ranking were infection,
allograft fractures, and nonunion, which is similar to our
observed results.
Microwave-induced hyperthermia is an alternative
treatment for distal tibia osteosarcoma, which in this series
showed that it provided improved function compared with
transtibial amputation, without any apparent increase in
death, local recurrence, or complications. However, these
findings should be replicated in larger studies with longer
mean followups, and in studies that compare microwave-
induced hyperthermia with conventional limb-sparing
approaches.
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